Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies

Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD2 Antibody

(2014) Nikolai Siebert et al.   PLoS One

Methods for the selection of platelet products for alloimmune-refractory patients

(2014) Patricia M. Kopko et al.   TRANSFUSION

Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES

(2013) Per Sandgren et al.   TRANSFUSION

High-yield Platelet units revealed immediate pH decline and delayed mitochondrial dysfunction during storage in 100% plasma as compared with storage in SSP+

(2012) P. Sandgren et al.   VOX SANGUINIS

Clinical relevance of the HLA system in blood transfusion

(2011) C. J. Brown et al.   VOX SANGUINIS

Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura

(2010) T. Tsubakio et al.   BRITISH JOURNAL OF HAEMATOLOGY

Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff

(2010) Danielle M. Carrick et al.   TRANSFUSION

A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester

(2009) Michael Miksa et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Platelet transfusion refractoriness

(2008) Eldad Hod et al.   BRITISH JOURNAL OF HAEMATOLOGY